Third, this is an in vitro study to modify the pathogenesis of POAG by stimulating normal hTM cells with TGF-β2, further in vitro studies using glaucomatous hTM cells without using any glaucomatous stimuli like TGF-β2. The gene discussed is TGFB2; the disease is open-angle glaucoma.